Ki-67 Expression in Breast Cancer: Association with Molecular Classification and Prognostic Indicators
Indian Journal of Pharmaceutical and Biological Research · 30.06.2026 · 14 (02) · 254-261
DOI: 10.30750/ijpbr.14.2.46 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical and Biological Research, online erschienen am 30.06.2026. Verfasst von Sarmistha Subhadarsini und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction: Breast cancer is the most common malignancy in female and the second most common cause of deathin women. Prognostic factors are essential in identifying high-risk patients, where adjuvant therapy can improveoutcomes. Ki-67, a potential marker of breast cancer, has gained importance recently for predicting the responsiveness tochemotherapy. Different Molecular subtypes (Luminal A, Luminal B, HER2-enriched, Triple-negative/Basal-like) exhibitdiverse proliferative activities, influencing therapeutic strategies and prognostic assessments. Histopathological gradingfurther underscored tumour aggressiveness, particularly in HER2-enriched and Triple-negative/Basal-like subtypes withelevated Ki67 levels. Aims/Objectives: To evaluate the association of Ki-67 proliferative index with molecular subtypes& clinicopathological prognostic parameters in breast carcinoma.Materials and Methods: This is a retrospective study conducted between January 2024 and December 2025 .Ki-67expression was assessed in 45 cases of biopsy-proven primary breast carcinoma in patients , who underwent radicalor modified radical mastectomy . Association with other prognostic parameters ( tumour histological type, grade, andlymph node metastasis,ER PR,HER2 ,P53 & molecular subtypes), was evaluated .Statistical analysis was done by Chisquare test and a p value of
Zitieren
APA
Subhadarsini, S., Mishra, P., Kullu, A., & Dora, N. (2026). Ki-67 Expression in Breast Cancer: Association with Molecular Classification and Prognostic Indicators. Indian Journal of Pharmaceutical and Biological Research, 14(02), 254-261. https://doi.org/10.30750/ijpbr.14.2.46
Vancouver
Subhadarsini S, Mishra P, Kullu A, Dora N. Ki-67 Expression in Breast Cancer: Association with Molecular Classification and Prognostic Indicators. Indian Journal of Pharmaceutical and Biological Research. 2026;14(02):254-261. doi:10.30750/ijpbr.14.2.46
BibTeX
@article{Subhadarsini2026,
author = {Subhadarsini, Sarmistha and Mishra, Puspanjali and Kullu, Anjana and Dora, Netrananda},
title = {Ki-67 Expression in Breast Cancer: Association with Molecular Classification and Prognostic Indicators},
journal = {Indian Journal of Pharmaceutical and Biological Research},
year = {2026},
volume = {14},
number = {02},
pages = {254--261},
doi = {10.30750/ijpbr.14.2.46}
}
EUVIMED